SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-009361
Filing Date
2015-11-04
Accepted
2015-11-04 16:21:18
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aimt-10q_20150930.htm 10-Q 1984616
2 EX-10.1 aimt-ex101_74.htm EX-10.1 54349
3 EX-31.1 aimt-ex311_9.htm EX-31.1 11913
4 EX-31.2 aimt-ex312_7.htm EX-31.2 11924
5 EX-32.1 aimt-ex321_8.htm EX-32.1 8678
  Complete submission text file 0001564590-15-009361.txt   6387946

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aimt-20150930.xml EX-101.INS 1376064
7 XBRL TAXONOMY EXTENSION SCHEMA aimt-20150930.xsd EX-101.SCH 33130
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aimt-20150930_cal.xml EX-101.CAL 37433
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aimt-20150930_def.xml EX-101.DEF 137546
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aimt-20150930_lab.xml EX-101.LAB 307436
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aimt-20150930_pre.xml EX-101.PRE 235311
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37519 | Film No.: 151197186
SIC: 2834 Pharmaceutical Preparations